pyridoxal has been researched along with deferoxamine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoy, T; Humphrys, J; Jacobs, A; Ponka, P; Williams, A | 1 |
| Campbell, RA; Gale, GR; Jones, MM; Litchenberg, WH; Singh, PK; Smith, AB | 1 |
| Eisenstein, RS; Garcia-Mayol, D; Munro, HN; Pettingell, W | 1 |
| Baker, E; Richardson, DR | 1 |
| van Asbeck, BS; van der Wal, NA; van Dijk, A; van Oirschot, JF; Verhoef, J | 1 |
| Finch, CA; Huebers, HA; Kim, BK | 1 |
| Baker, E; Vitolo, ML; Webb, J | 1 |
| Finch, CA; Johnson, DK; Pippard, MJ | 1 |
| Ponka, P; Richardson, DR; Tran, EH | 1 |
| Ponka, P; Richardson, DR | 1 |
| Crowe, A; Morgan, EH | 1 |
| Bhattacharya, M; Chemtob, S; Hanna, N; Hardy, P; Lachapelle, P; Ponka, P; Varma, DR | 1 |
| Milnes, K; Richardson, DR | 1 |
| Gao, J; Richardson, DR | 1 |
| Breuer, W; Cabantchik, ZI; Hershko, C; Konijn, AM; Link, G; Ponka, P | 1 |
| Richardson, DR | 1 |
| Cabantchik, ZI; Hershko, CM; Konijn, AM; Link, GM | 1 |
| Bast, A; den Hartog, GJ; Kaiserová, H; Kvasnicková, E; Schröterová, L; Simůnek, T | 1 |
| Kovacevic, Z; Richardson, DR; Yu, Y | 1 |
1 review(s) available for pyridoxal and deferoxamine
| Article | Year |
|---|---|
Therapeutic potential of iron chelators in cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Deferoxamine; Humans; Iron; Iron Chelating Agents; Isoniazid; Neoplasms; Pyridoxal; Thiosemicarbazones; Tumor Suppressor Protein p53 | 2002 |
18 other study(ies) available for pyridoxal and deferoxamine
| Article | Year |
|---|---|
Effective iron chelation following oral administration of an isoniazid-pyridoxal hydrazone.
Topics: Animals; Deferoxamine; Heme; Iron; Iron Chelating Agents; Isoniazid; Liver; Male; Pyridoxal; Pyridoxine; Rats; Spleen | 1979 |
Comparative iron mobilizing actions of deferoxamine, 1,2-dimethyl-3-hydroxypyrid-4-one, and pyridoxal isonicotinoyl hydrazone in iron hydroxamate-loaded mice.
Topics: Animals; Deferiprone; Deferoxamine; Hydroxamic Acids; Iron; Isoniazid; Male; Mice; Mice, Inbred Strains; Pyridones; Pyridoxal; Tissue Distribution | 1991 |
Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron.
Topics: Animals; Cell Line; Deferoxamine; Enzyme Induction; Ferritins; Fibroblasts; Heme; Heme Oxygenase (Decyclizing); Iron; Isoniazid; Kinetics; Pyridoxal; Rats | 1991 |
The release of iron and transferrin from the human melanoma cell.
Topics: Antigens, Neoplasm; Cell Line; Deferoxamine; Humans; Iron; Iron Chelating Agents; Isoniazid; Kinetics; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Pyridoxal; Transferrin | 1991 |
Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine.
Topics: Animals; Cell Survival; Cells, Cultured; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; Free Radicals; Hydrazones; Hydroxides; Hydroxyl Radical; Male; Paraquat; Pulmonary Alveoli; Putrescine; Pyridoxal; Rats; Rats, Inbred Strains | 1990 |
Effectiveness of oral iron chelators assayed in the rat.
Topics: Administration, Oral; Animals; Deferoxamine; Female; Ferritins; Iron Chelating Agents; Isoniazid; Male; Pyridoxal; Rats; Rats, Inbred Strains | 1987 |
Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
Topics: Animals; Cells, Cultured; Chelating Agents; Deferoxamine; Iron; Isoniazid; Liver; Male; Pyridoxal; Rats; Rats, Inbred Strains; Transferrin | 1985 |
A rapid assay for evaluation of iron-chelating agents in rats.
Topics: Animals; Bile; Deferoxamine; Female; Ferritins; Injections, Intravenous; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Liver; Male; Pyridoxal; Rats; Rats, Inbred Strains; Time Factors | 1981 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
Topics: Antineoplastic Agents; Biological Transport, Active; Cell Division; Deferoxamine; Gallium; Humans; Iron; Iron Chelating Agents; Isoniazid; Pyridoxal; Transferrin; Tumor Cells, Cultured | 1995 |
The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Topics: Deferoxamine; DNA; Humans; Iron; Iron Chelating Agents; Isoniazid; Neuroblastoma; Osmolar Concentration; Pyridoxal; Thymidine; Transferrin; Tumor Cells, Cultured | 1994 |
Effects of chelators on iron uptake and release by the brain in the rat.
Topics: 2,2'-Dipyridyl; Aging; Animals; Biological Transport; Bone and Bones; Brain; Deferiprone; Deferoxamine; Female; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Kidney; Liver; Male; Pentetic Acid; Pyridones; Pyridoxal; Rats; Rats, Wistar | 1994 |
Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Deferoxamine; Disease Models, Animal; Electroretinography; Humans; Hydrogen Peroxide; Infant, Newborn; Iron Chelating Agents; Isoniazid; Malondialdehyde; Oxidative Stress; Peroxides; Pyridoxal; Retina; Swine; Vision Disorders | 1997 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
Topics: Antineoplastic Agents; Apoptosis; Benzaldehydes; Cell Cycle; Cell Division; Deferoxamine; DNA Fragmentation; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Ferritins; Growth Inhibitors; HL-60 Cells; Humans; Hydrazones; Iron; Iron Chelating Agents; Isoniazid; Ligands; Molecular Structure; Naphthols; Neoplasm Proteins; Neoplasms; Pyridoxal; Structure-Activity Relationship; Transferrin; Tumor Cells, Cultured | 1997 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression.
Topics: Antineoplastic Agents; Cell Cycle; Cyclins; Deferoxamine; Female; Genes, Retinoblastoma; Humans; Hydroxyurea; Iron; Iron Chelating Agents; Isoniazid; Pyridoxal; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells.
Topics: Animals; Animals, Newborn; Blood Transfusion; Cells, Cultured; Deferoxamine; Female; Ferritins; Heart; Iron; Iron Chelating Agents; Iron Radioisotopes; Isoniazid; Kinetics; Pyridoxal; Rats; Rats, Wistar | 2003 |
Iron chelation therapy.
Topics: Administration, Oral; Benzoates; beta-Thalassemia; Chelation Therapy; Chemical and Drug Induced Liver Injury; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Humans; Infusions, Intravenous; Iron Chelating Agents; Iron Overload; Isoniazid; Pyridones; Pyridoxal; Survival; Triazoles | 2005 |
Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
Topics: Aldehydes; Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deferoxamine; Doxorubicin; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrazones; Hydrogen Peroxide; Iron; Iron Chelating Agents; Iron Compounds; Isoniazid; Lipid Peroxidation; Lung Neoplasms; Oxidative Stress; Pyridoxal; Razoxane; Time Factors | 2006 |
Chelators to the rescue: different horses for different courses!
Topics: Aldehydes; Animals; Deferoxamine; Humans; Hydrazones; Iron Chelating Agents; Iron Overload; Isoniazid; Myocardial Reperfusion Injury; Neoplasms; Pyridines; Pyridoxal; Rats; Reactive Oxygen Species; Thiosemicarbazones | 2011 |